Kinga Malottki
Reading, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Uncertainties in evaluating the health-related quality of life and disease burden of people with rare diseases and their caregivers in NICE HST submissions.
Journal: Orphanet journal of rare diseases
Published: March 21, 2024
The Challenge for Orphan Drugs Remains: Three Case Studies Demonstrating the Impact of Changes to NICE Methods and Processes and Alternative Mechanisms to Value Orphan Products.
Journal: PharmacoEconomics - open
Published: September 26, 2022
Assessing the Quality and Coherence of Network Meta-Analyses of Biologics in Plaque Psoriasis: What Does All This Evidence Synthesis Tell Us?
Journal: Dermatology and therapy
Published: September 24, 2020
Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year.
Journal: The Journal of dermatological treatment
Published: March 24, 2020
The Cancer Drugs Fund in Practice and Under the New Framework.
Journal: PharmacoEconomics
Published: April 04, 2019
Erratum to: Methods for evaluating medical tests and biomarkers.
Journal: Diagnostic and prognostic research
Published: March 03, 2017
Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 15, 2015
Research methods to change clinical practice for patients with rare cancers.
Journal: The Lancet. Oncology
Published: June 30, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026